Saltz L B, Kelsen D P
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Annu Rev Med. 1997;48:191-202. doi: 10.1146/annurev.med.48.1.191.
The adjuvant therapy of colorectal cancer has seen many important advances in recent years. Chemotherapy improves long-term disease-free survival rates in high-risk patients with resected colon cancer. Combined modality therapy, using surgery, radiation therapy, and chemotherapy, improves both local control and survival in patients with stage II and III rectal cancer. We examine in detail the data on which current recommendations for adjuvant treatments are based. We also review some of the more promising experimental approaches currently under investigation.
近年来,结直肠癌的辅助治疗取得了许多重要进展。化疗可提高高危结肠癌切除患者的长期无病生存率。采用手术、放疗和化疗的综合治疗方式可提高II期和III期直肠癌患者的局部控制率和生存率。我们详细研究了当前辅助治疗建议所依据的数据。我们还回顾了一些目前正在研究的更有前景的实验方法。